Christopher Jones - Nortech Systems CFO VP
| NSYS Stock | USD 10.14 0.15 1.46% |
Insider
Christopher Jones is CFO VP of Nortech Systems Incorporated
| Age | 53 |
| Phone | 952 345 2244 |
| Web | https://www.nortechsys.com |
Christopher Jones Latest Insider Activity
Tracking and analyzing the buying and selling activities of Christopher Jones against Nortech Systems stock is an integral part of due diligence when investing in Nortech Systems. Christopher Jones insider activity provides valuable insight into whether Nortech Systems is net buyers or sellers over its current business cycle. Note, Nortech Systems insiders must abide by specific rules, including filing SEC forms every time they buy or sell Nortech Systems'shares to prevent insider trading or benefiting illegally from material non-public information that their positions give them access to.
Christopher Jones over six months ago Acquisition by Christopher Jones of 108 shares of Becton Dickinson subject to Rule 16b-3 |
Nortech Systems Management Efficiency
The company has return on total asset (ROA) of 0.0348 % which means that it generated a profit of $0.0348 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of 0.1366 %, meaning that it created $0.1366 on every $100 dollars invested by stockholders. Nortech Systems' management efficiency ratios could be used to measure how well Nortech Systems manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Showing other executives | INSIDER Age | ||
| Erik Mickelson | Paragon 28 | 42 | |
| Mark Quick | Orthofix Medical | N/A | |
| Christopher Lesovitz | STRATA Skin Sciences | 41 | |
| Jean Holloway | Artivion | 63 | |
| Jon Salveson | Artivion | 56 | |
| Andrew Green | Artivion | 52 | |
| Mark MD | Bluejay Diagnostics | N/A | |
| Daniel Bevevino | Artivion | 61 | |
| B Johnson | Paragon 28 | 68 | |
| James Bullock | Artivion | 64 | |
| Matthew Getz | Artivion | 56 | |
| Scott Capps | Artivion | 53 | |
| Rebecca Kuhn | Neuropace | 64 | |
| Matt Jarboe | Paragon 28 | N/A | |
| Richard Ginn | Tenon Medical | 59 | |
| Kenneth CPA | Bluejay Diagnostics | 44 | |
| Lee Rosenthal | Paragon 28 | N/A | |
| Benedict MD | enVVeno Medical Corp | 68 | |
| Robert Moccia | STRATA Skin Sciences | 65 | |
| Paul Verrastro | CVRx Inc | 62 | |
| Marshall Stanton | Artivion | 64 | |
Management Performance
| Return On Equity | 0.14 | ||||
| Return On Asset | 0.0348 |
Nortech Systems Leadership Team
Elected by the shareholders, the Nortech Systems' board of directors comprises two types of representatives: Nortech Systems inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Nortech. The board's role is to monitor Nortech Systems' management team and ensure that shareholders' interests are well served. Nortech Systems' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Nortech Systems' outside directors are responsible for providing unbiased perspectives on the board's policies.
| Mark Hooley, Secretary | ||
| Cathy Vold, VP Services | ||
| Corey Hancock, Vice Development | ||
| Christopher Jones, CFO VP | ||
| Jay Miller, Interim President | ||
| Curtis Steichen, Chief Marketing and Sales Officer and Sr. VP | ||
| John Lindeen, Senior Operations | ||
| Monica Hamling, Vice Culture | ||
| Andrew CPA, CFO Finance | ||
| Alan Nordstrom, Corporate Controller |
Nortech Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Nortech Systems a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.14 | ||||
| Return On Asset | 0.0348 | ||||
| Profit Margin | 0.03 % | ||||
| Operating Margin | (0.01) % | ||||
| Current Valuation | 46.26 M | ||||
| Shares Outstanding | 2.76 M | ||||
| Shares Owned By Insiders | 65.09 % | ||||
| Shares Owned By Institutions | 5.11 % | ||||
| Number Of Shares Shorted | 2.83 K | ||||
| Price To Earning | 4.08 X |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Nortech Stock Analysis
When running Nortech Systems' price analysis, check to measure Nortech Systems' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Nortech Systems is operating at the current time. Most of Nortech Systems' value examination focuses on studying past and present price action to predict the probability of Nortech Systems' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Nortech Systems' price. Additionally, you may evaluate how the addition of Nortech Systems to your portfolios can decrease your overall portfolio volatility.